Skip to main content
. 2022 Jan 10;83(4):346–355. doi: 10.1016/j.humimm.2022.01.004

Fig. 1.

Fig. 1

Graphical representation of designing and functioning of Bispecific antibody (BsAb) against SARS-CoV-2 and DPP4 receptor along with the inhibition of ACE-2 receptor with anti-viral peptide.